Last reviewed · How we verify
NCT05851989: SPARTA
Study on Prognosis of Acutely Ruptured Intracranial Aneurysms
trial in Aneurysmal Subarachnoid Hemorrhage in 880 participants. Currently enrolling.
14 July 2025
Quick facts
| Lead sponsor | Haaglanden Medical Centre |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 880 |
| Start date | 14 July 2021 |
| Primary completion | 14 July 2025 |
| Estimated completion | 14 July 2034 |
| Sites | 6 locations across Netherlands |
Conditions studied
- Aneurysmal Subarachnoid Hemorrhage — all drugs for Aneurysmal Subarachnoid Hemorrhage →
- Endovascular Procedures — all drugs for Endovascular Procedures →
- Craniotomy — all drugs for Craniotomy →
- Patient Outcome Assessment — all drugs for Patient Outcome Assessment →
Sponsor
Haaglanden Medical Centre — full company profile →
Who can join
18 and older, any sex, with Aneurysmal Subarachnoid Hemorrhage or Endovascular Procedures. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The SPARTA study is a prospective multicenter observational trial in the Netherlands with the aim of identifying the best clinical care in patients with aneurysmal subarachnoidal haemorrhage. Differences in outcome between surgical treatment and endovascular treatment will be explored. Furthermore, cost effectiveness and radiological prognostic factors will be examined.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Study on prognosis of acutely ruptured intracranial aneurysms (SPARTA): a protocol for a multicentre prospective cohort study.
Hamming AL, van Dijck JTJM, Visser T, Baarse M, et al · · 2024 · cited 4× · PMID 38368355 · DOI 10.1186/s12883-024-03567-6 -
Treatment variation in acute management of patients with aneurysmal subarachnoid hemorrhage: a multicenter case vignette study.
Vreeburg RJG, de Groot D, Bandral HV, Verbaan D, et al · · 2026 · PMID 42182576 · DOI 10.1016/j.bas.2026.106071
Verify or expand the search:
- PubMed search for NCT05851989
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Aneurysmal Subarachnoid Hemorrhage
Currently open trials in the same condition.
- NCT06863480 — Tocilizumab-aazg for Hemorrhage: Reduction of Ischemic Vascular Events · Phase 1 · recruiting
- NCT06409364 — FLudrocortisone Administration in Aneurysmal Subarachnoid Haemorrhage · Phase 2 · recruiting
- NCT06494436 — Microvention AnEurysm & STroke Real-life Data cOllection · recruiting
- NCT06548477 — Human Albumin for Clinical Outcome in Aneurysmal Subarachnoid Hemorrhages · NA · recruiting
- NCT06288659 — aSAH Treatment Based on Intraventricular ICP Monitoring: A Prospective, Multicenter, Randomized and Controlled Trial · NA · recruiting
Other Haaglanden Medical Centre trials
Trials by the same sponsor.
- NCT06204341 — Towards Optimal Treatment for High Risk Prostate Cancer · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05851989 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Haaglanden Medical Centre
- Last refreshed: 25 March 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05851989.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing